Colombia vs Togo: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Colombia
89.0%
in 2025
Togo
89.0%
in 2025
Colombia rank
70th
Togo rank
70th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Colombia
- Togo
How they compare
Colombia currently reports 89.0% against 89.0% in Togo, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Togo ahead.
Colombia ranks 70th and Togo ranks 70th of 192 countries.
Across the 3 decades both report, Colombia averaged higher in 1 and Togo in 1.
Head to head by decade
| Decade | Colombia | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | β |
| 2010s | 78.6% | 43.9% | 34.7% | Colombia |
| 2020s | 88.0% | 89.0% | 1.0% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Colombia or Togo?
- Colombia, at 89.0% against 89.0% in Togo as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Colombia and Togo?
- 0.0%, with Colombia ahead.
- How many years of comparable data are there for Colombia and Togo?
- 18 years are reported by both, from 2008 to 2025.
- How do Colombia and Togo rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Colombia ranks 70th and Togo ranks 70th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.